Moxifloxacin can treat mycoplasma bronchitis, the use of drugs need to follow the doctor’s instructions and pay attention to contraindications. 1. Moxifloxacin belongs to 8-methoxy fluoroquinolone antimicrobials, which have broad-spectrum antimicrobial activities against atypical microorganisms (such as Mycoplasma, Chlamydia, Legionella), Gram-positive and negative bacteria, anaerobic bacteria, acid-resistant bacteria, etc., and the pathogenesis of mycoplasma bronchiolitis is related to mycoplasma infections, so this drug can treat mycoplasma bronchiolitis. 2. Moxifloxacin may cause side effects such as nausea, diarrhea, headache and dizziness, prolongation of the QT interval, and is contraindicated in persons under 18 years of age, pregnant and lactating females, persons who are allergic to quinolones or to this medication, persons who have hepatic impairment and transaminase elevation of greater than five times the upper limit of normal, and persons who have uncorrected hypokalemia. Moxifloxacin is a prescription drug, and its use must be in accordance with medical advice.